These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 28447743)

  • 21. Impact of Helicobacter pylori infection on the humoral immune response to MUC1 peptide in patients with chronic gastric diseases and gastric cancer.
    Klaamas K; Kurtenkov O; von Mensdorff-Pouilly S; Shljapnikova L; Miljukhina L; Brjalin V; Lipping A
    Immunol Invest; 2007; 36(4):371-86. PubMed ID: 17691020
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunoreactivity of the fully humanized therapeutic antibody PankoMab-GEX™ is an independent prognostic marker for breast cancer patients.
    Heublein S; Mayr D; Egger M; Karsten U; Goletz S; Angele M; Gallwas J; Jeschke U; Ditsch N
    J Exp Clin Cancer Res; 2015 May; 34(1):50. PubMed ID: 25986064
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-MUC1 Antibody in Nipple Aspirate Fluids Correlates with Tumor Aggressiveness in Breast Cancer: A Feasibility Study.
    Menekse E; McKolanis J; Finn OJ; McAuliffe PF; Johnson R; Soran A
    Dis Markers; 2015; 2015():179689. PubMed ID: 26693201
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical and prognostic significance of preoperative serum CA153, CEA and TPS levels in patients with primary breast cancer].
    Chen Y; Zheng YH; Lin YY; Hu MH; Chen YS
    Zhonghua Zhong Liu Za Zhi; 2011 Nov; 33(11):842-6. PubMed ID: 22335950
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autoantibodies to aberrantly glycosylated MUC1 in early stage breast cancer are associated with a better prognosis.
    Blixt O; Bueti D; Burford B; Allen D; Julien S; Hollingsworth M; Gammerman A; Fentiman I; Taylor-Papadimitriou J; Burchell JM
    Breast Cancer Res; 2011 Mar; 13(2):R25. PubMed ID: 21385452
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of mucin 1 possessing a 3'-sulfated core1 in recurrent and metastatic breast cancer.
    Ideo H; Hinoda Y; Sakai K; Hoshi I; Yamamoto S; Oka M; Maeda K; Maeda N; Hazama S; Amano J; Yamashita K
    Int J Cancer; 2015 Oct; 137(7):1652-60. PubMed ID: 25787775
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vaccination of high-risk breast cancer patients with mucin-1 (MUC1) keyhole limpet hemocyanin conjugate plus QS-21.
    Gilewski T; Adluri S; Ragupathi G; Zhang S; Yao TJ; Panageas K; Moynahan M; Houghton A; Norton L; Livingston PO
    Clin Cancer Res; 2000 May; 6(5):1693-701. PubMed ID: 10815887
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Humoral immune response induced by the protein core of MUC1 mucin in pregnant and healthy women.
    Croce MV; Isla-Larrain MT; Capafons A; Price MR; Segal-Eiras A
    Breast Cancer Res Treat; 2001 Sep; 69(1):1-11. PubMed ID: 11759823
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human carcinoma-associated and salivary mucins detected by anti-bovine submaxillary mucin antibodies.
    Golubović SJ; Bojić-Trbojević ZT
    Biochemistry (Mosc); 2006; 71 Suppl 1():S9-17. PubMed ID: 16487075
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endogenous antibody responses to mucin 1 in a large multiethnic cohort of patients with breast cancer and healthy controls: Role of immunoglobulin and Fcγ receptor genes.
    Pandey JP; Namboodiri AM; Wolf B; Iwasaki M; Kasuga Y; Hamada GS; Tsugane S
    Immunobiology; 2018 Feb; 223(2):178-182. PubMed ID: 29074302
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lack of polymorphism in MUC1 tandem repeats in cancer cells is related to breast cancer progression in Japanese women.
    Kawaguchi T; Takazawa H; Imai S; Morimoto J; Watanabe T
    Breast Cancer Res Treat; 2005 Aug; 92(3):223-30. PubMed ID: 16155793
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New immunoassays for MUC1 in breast cancer.
    Norum LF; Sauren AM; Rye PD; Nustad K
    Tumour Biol; 2001; 22(4):216-22. PubMed ID: 11399946
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of IgG antibodies to MUC1 and survival in patients with epithelial ovarian cancer.
    Oei AL; Moreno M; Verheijen RH; Sweep FC; Thomas CM; Massuger LF; von Mensdorff-Pouilly S
    Int J Cancer; 2008 Oct; 123(8):1848-53. PubMed ID: 18661524
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tecemotide: an antigen-specific cancer immunotherapy.
    Wurz GT; Kao CJ; Wolf M; DeGregorio MW
    Hum Vaccin Immunother; 2014; 10(11):3383-93. PubMed ID: 25483673
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Designing a recombinant chimeric construct contain MUC1 and HER2 extracellular domain for prediagnostic breast cancer.
    Gheybi E; Amani J; Salmanian AH; Mashayekhi F; Khodi S
    Tumour Biol; 2014 Nov; 35(11):11489-97. PubMed ID: 25128064
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum CA153 as biomarker for cancer and noncancer diseases.
    Li X; Xu Y; Zhang L
    Prog Mol Biol Transl Sci; 2019; 162():265-276. PubMed ID: 30905456
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amplified Detection of Breast Cancer Autoantibodies Using MUC1-Based Tn Antigen Mimics.
    Guillen-Poza PA; Sánchez-Fernández EM; Artigas G; García Fernández JM; Hinou H; Ortiz Mellet C; Nishimura SI; Garcia-Martin F
    J Med Chem; 2020 Aug; 63(15):8524-8533. PubMed ID: 32672464
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of circulating natural antibodies against CD25, MUC1, and VEGFR1 for early diagnosis of non-small cell lung cancer.
    Liu S; Zhang X; Jiang Q; Liang T
    FEBS Open Bio; 2020 Jul; 10(7):1288-1294. PubMed ID: 32392378
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The use of a novel MUC1 antibody to identify cancer stem cells and circulating MUC1 in mice and patients with pancreatic cancer.
    Curry JM; Thompson KJ; Rao SG; Besmer DM; Murphy AM; Grdzelishvili VZ; Ahrens WA; McKillop IH; Sindram D; Iannitti DA; Martinie JB; Mukherjee P
    J Surg Oncol; 2013 Jun; 107(7):713-22. PubMed ID: 23335066
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical study of serum tissue polypeptide-specific antigen in breast cancer].
    Zheng H; He BF; Luo RC; You CX; Mai GF; Lu HF
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Aug; 23(8):823-5. PubMed ID: 12919909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.